Cargando…

Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans

BACKGROUND: Dyslipidaemia is a major risk factor for atherosclerosis and cardiovascular diseases. The molecular mechanisms that translate dyslipidaemia into atherogenesis and reliable markers of its progression are yet to be fully elucidated. To address this issue, we conducted a comprehensive metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olkowicz, Mariola, Czyzynska-Cichon, Izabela, Szupryczynska, Natalia, Kostogrys, Renata B., Kochan, Zdzislaw, Debski, Janusz, Dadlez, Michal, Chlopicki, Stefan, Smolenski, Ryszard T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789501/ https://www.ncbi.nlm.nih.gov/pubmed/33407555 http://dx.doi.org/10.1186/s12967-020-02663-8

Ejemplares similares

Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
por: Rizzo, Manfredi, et al.
Publicado: (2011)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
por: Agarwala, Anandita, et al.
Publicado: (2020)

Pomegranate Seed Oil as a Source of Conjugated Linolenic Acid (CLnA) Has No Effect on Atherosclerosis Development but Improves Lipid Profile and Affects the Expression of Lipid Metabolism Genes in apoE/LDLR(−/−) Mice
por: Franczyk-Żarów, Magdalena, et al.
Publicado: (2023)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

Functional and Biochemical Endothelial Profiling In Vivo in a Murine Model of Endothelial Dysfunction; Comparison of Effects of 1-Methylnicotinamide and Angiotensin-converting Enzyme Inhibitor
por: Bar, Anna, et al.
Publicado: (2017)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Lorenzatti, Alberto J, et al.
Publicado: (2020)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021)

Effects of Low Carbohydrate High Protein (LCHP) diet on atherosclerotic plaque phenotype in ApoE/LDLR(−/−) mice: FT-IR and Raman imaging
por: Wrobel, T. P., et al.
Publicado: (2015)

High Throughput Procedure for Comparative Analysis of In Vivo Cardiac Glucose or Amino Acids Use in Cardiovascular Pathologies and Pharmacological Treatments
por: Tomczyk, Marta, et al.
Publicado: (2021)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020)

Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
por: Paublini, Hernán, et al.
Publicado: (2023)

Low Dose Curcumin Administered in Hyaluronic Acid-Based Nanocapsules Induces Hypotensive Effect in Hypertensive Rats
por: Czyzynska-Cichon, Izabela, et al.
Publicado: (2021)

Relationship between Atherogenic Dyslipidaemia and Lipid Triad with Different Scales of Overweight and Obesity in 418,343 Spanish Workers
por: Busquets-Cortés, Carla, et al.
Publicado: (2022)

LSEC Fenestrae Are Preserved Despite Pro-inflammatory Phenotype of Liver Sinusoidal Endothelial Cells in Mice on High Fat Diet
por: Kus, Edyta, et al.
Publicado: (2019)

Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia
por: Fruchart, Jean-Charles
Publicado: (2017)

Systemic Administration of Insulin Receptor Antagonist Results in Endothelial and Perivascular Adipose Tissue Dysfunction in Mice
por: Proniewski, Bartosz, et al.
Publicado: (2021)

Urban-Rural Differences in Atherogenic Dyslipidaemia (URDAD Study): A Retrospective Report on Diabetic and Non-diabetic Subjects of Northern India
por: Agrawal, Poonam, et al.
Publicado: (2014)

Atherogenic dyslipidaemia and cardiovascular events in patients with diabetes or pre-diabetes and stable coronary artery disease: a prospective, cohort study
por: Jin, Jing-Lu, et al.
Publicado: (2021)

The association of Helicobacter Pylori infection with dyslipidaemia and other atherogenic factors in dyspeptic patients at St. Paul's Hospital Millennium Medical College
por: Hashim, Mujahid, et al.
Publicado: (2022)

Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2017)

Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin
por: Han, Ji Soo, et al.
Publicado: (2018)

Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021)

SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
por: Olkowicz, Mariola, et al.
Publicado: (2021)

Distinct Chemical Changes in Abdominal but Not in Thoracic Aorta upon Atherosclerosis Studied Using Fiber Optic Raman Spectroscopy
por: Czamara, Krzysztof, et al.
Publicado: (2020)

Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study
por: Orsi, Emanuela, et al.
Publicado: (2021)

Dynamic Metabolic Changes During Prolonged Ex Situ Heart Perfusion Are Associated With Myocardial Functional Decline
por: Olkowicz, Mariola, et al.
Publicado: (2022)

Deletion of Mcpip1 in Mcpip1(fl/fl)Alb(Cre) mice recapitulates the phenotype of human primary biliary cholangitis
por: Kotlinowski, Jerzy, et al.
Publicado: (2021)

The year in dyslipidaemia 2008 /
Publicado: (2009)

The year in dyslipidaemia 2007
Publicado: (2008)

Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)

Ribosomal DNA status inferred from DNA cloud assays and mass spectrometry identification of agarose-squeezed proteins interacting with chromatin (ASPIC-MS)
por: Krol, Kamil, et al.
Publicado: (2017)

The year in dyslipidaemia : version en español 2009-2010 /
Publicado: (2010)

Dyslipidaemia in Rheumatological Autoimmune Diseases
por: Toms, Tracey E, et al.
Publicado: (2011)

The year in dyslipidaemia 2005-2006
Publicado: (2006)

Angina due to hypertension and dyslipidaemia
por: Fox, Kim
Publicado: (2019)

Nutraceuticals in Paediatric Patients with Dyslipidaemia
por: Banderali, Giuseppe, et al.
Publicado: (2022)

Fixed Combination for the Treatment of Dyslipidaemia
por: Ferri, Nicola, et al.
Publicado: (2023)

Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
por: Raal, Frederick J, et al.
Publicado: (2013)

The metabolic fate of oxaliplatin in the biological milieu investigated during in vivo lung perfusion using a unique miniaturized sampling approach based on solid-phase microextraction coupled with liquid chromatography-mass spectrometry
por: Olkowicz, Mariola, et al.
Publicado: (2022)

Cross-regulation between Aurora B and Citron kinase controls midbody architecture in cytokinesis
por: McKenzie, Callum, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6n93c6ph1v5j9utoadkmecg20b